A cancer genetics toolkit improves access to genetic services through documentation and use of the family history by primary-care clinicians

Genetics in Medicine

Volumn 16, Issue 1, 2014, Pages 60-69

  Scheuner, Maren T ^a,b   Hamilton, Alison B ^a,b   Peredo, Jane ^a   Sale, Taylor J ^a   Austin, Colletta ^a   Gilman, Stuart C ^c   Bowen, M Scott ^d   Goldzweig, Caroline Lubick ^a,b   Lee, Martin ^a,e   Mittman, Brian S ^a   Yano, Elizabeth M ^a,e  

^a VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

family history; hereditary cancer; referral

Indexed keywords

ADULT; ARTICLE; CANCER FAMILY; CANCER GENETICS; CANCER GENETICS TOOLKIT; CLINICAL ASSESSMENT TOOL; CLINICAL GENETICS; CONSULTATION; ELECTRONIC MEDICAL RECORD; FAMILIAL CANCER; FAMILY HISTORY; FEMALE; GENETIC RISK; GENETIC SCREENING; GENETIC SERVICE; HEALTH CARE ACCESS; HEALTH CARE SURVEY; HEALTH PERSONNEL ATTITUDE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL DOCUMENTATION; MEDICAL RECORD REVIEW; MIDDLE AGED; NEEDS ASSESSMENT; NURSE PRACTITIONER; PATIENT REFERRAL; PHYSICIAN; PHYSICIAN ASSISTANT; PRIMARY MEDICAL CARE; PROFESSIONAL KNOWLEDGE; RISK ASSESSMENT; SEMI STRUCTURED INTERVIEW;

COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; DOCUMENTATION; ELECTRONIC HEALTH RECORDS; FAMILY HEALTH; FEMALE; GENETIC SERVICES; HEREDITARY BREAST AND OVARIAN CANCER SYNDROME; HOSPITALS, VETERANS; HUMANS; INTERVIEWS AS TOPIC; MEDICAL HISTORY TAKING; PRIMARY HEALTH CARE; REMINDER SYSTEMS;

EID: 84893561578     PISSN: 10983600     EISSN: 15300366     Source Type: Journal    
DOI: 10.1038/gim.2013.75     Document Type: Article

References (38)

1. National Comprehensive Cancer Network. Clinical Practice Guidelines in Oncology. Genetic/Familial High-Risk Assessment: Breast and Ovarian. Version I.2011 7 April 2011. http://www.nccn.org/professionals. Accessed 20 November 2012.
2. National Comprehensive Cancer Network. Clinical Practice Guidelines in Oncology. Colorectal cancer screening. Version 2.2011, 22 October 2010. http://www.nccn.org/professionals. Accessed 20 November 2012.
3. Sardanelli F, Podo F, Santoro F, et al.; High Breast Cancer Risk Italian 1 (HIBCRIT-1) Study. Multicenter surveillance of women at high genetic breast cancer risk using mammography, ultrasonography, and contrast-enhanced magnetic resonance imaging (the high breast cancer risk Italian 1 study): final results. Invest Radiol 2011;46:94-105.
4. Huang M, Sun C, Boyd-Rogers S, et al. Prospective study of combined colon and endometrial cancer screening in women with lynch syndrome: a patientcentered approach. J Oncol Pract 2011;7:43-47.
5. Rebbeck TR, Lynch HT, Neuhausen SL, et al.; Prevention and Observation of Surgical End Points Study Group. Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations. N Engl J Med 2002;346:1616-1622.
6. Rebbeck TR, Friebel T, Lynch HT, et al. Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group. J Clin Oncol 2004;22:1055-1062.
7. Eisen A, Lubinski J, Klijn J, et al. Breast cancer risk following bilateral oophorectomy in BRCA1 and BRCA2 mutation carriers: an international casecontrol study. J Clin Oncol 2005;23:7491-7496.
8. Järvinen HJ, Aarnio M, Mustonen H, et al. Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology 2000;118:829-834.
9. Schmeler KM, Lynch HT, Chen LM, et al. Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome. N Engl J Med 2006;354:261-269.
10. Narod SA, Brunet JS, Ghadirian P, et al.; Hereditary Breast Cancer Clinical Study Group. Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. Hereditary Breast Cancer Clinical Study Group. Lancet 2000;356:1876-1881.
11. Chan AT, Lippman SM. Aspirin and colorectal cancer prevention in Lynch syndrome. Lancet 2011;378:2051-2052.
12. U.S. Preventive Services Task Force. Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: recommendation statement. Ann Intern Med 2005;143:355-361.
13. Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group. Recommendations from the EGAPP Working Group: genetic testing strategies in newly diagnosed individuals with colorectal cancer aimed at reducing morbidity and mortality from Lynch syndrome in relatives. Genet Med 2009;11:35-41.
14. Bellcross CA, Kolor K, Goddard KA, Coates RJ, Reyes M, Khoury MJ. Awareness and utilization of BRCA1/2 testing among U.S. primary care physicians. Am J Prev Med 2011;40:61-66.
15. Baer HJ, Brawarsky P, Murray MF, Haas JS. Familial risk of cancer and knowledge and use of genetic testing. J Gen Intern Med 2010;25:717-724.
16. Trivers KF, Baldwin LM, Miller JW, et al. Reported referral for genetic counseling or BRCA 1/2 testing among United States physicians: a vignette-based study. Cancer 2011;117:5334-5343.
17. Scheuner MT, Sieverding P, Shekelle PG. Delivery of genomic medicine for common chronic adult diseases: a systematic review. JAMA 2008;299:1320-1334.
18. Burke W, Culver J, Pinsky L, et al. Genetic assessment of breast cancer risk in primary care practice. Am J Med Genet A 2009;149A:349-356.
19. Brierley KL, Campfield D, Ducaine W, et al. Errors in delivery of cancer genetics services: implications for practice. Conn Med 2010;74:413-423.
20. United Healthcare Center for Health Reform & Modernization. Personalized medicine: Trends and prospects for the new science of genetic testing and molecular diagnostics. Working Paper 7 March 2012, p 23. http://www. unitedhealthgroup.com/hrm/UNH-WorkingPaper7.pdf. Accessed 6 May 2012.
21. Curran GM, Mukherjee S, Allee E, Owen RR. A process for developing an implementation intervention: QUERI Series. Implement Sci 2008;3:17.
22. Mazmanian PE, Davis DA. Continuing medical education and the physician as a learner: guide to the evidence. JAMA 2002;288:1057-1060.
23. Oxman AD, Thomson MA, Davis DA, Haynes RB. No magic bullets: a systematic review of 102 trials of interventions to improve professional practice. CMAJ 1995;153:1423-1431.
24. Mansouri M, Lockyer J. A meta-analysis of continuing medical education effectiveness. J Contin Educ Health Prof 2007;27:6-15.
25. Khoury MJ, Coates RJ, Fennell ML, et al. Multilevel research and the challenges of implementing genomic medicine. J Natl Cancer Inst Monographs 2012;2012:112-120.
26. Yano EM, Washington DL, Goldzweig C, Caffrey C, Turner C. The organization and delivery of women's health care in Department of Veterans Affairs Medical Center. Womens Health Issues 2003;13:55-61.
27. Yano EM, Goldzweig C, Canelo I, Washington DL. Diffusion of innovation in women's health care delivery: the Department of Veterans Affairs' adoption of women's health clinics. Womens Health Issues 2006;16:226-235.
28. Richards T, Richards L. Using hierarchical categories in qualitative data analysis. In: Kelly U (ed). Computer-Aided Qualitative Data Analysis. Theory, Methods, and Practice. Sage: London, 1995:80-95.
29. Evans DC, Nichol WP, Perlin JB. Effect of the implementation of an enterprisewide Electronic Health Record on productivity in the Veterans Health Administration. Health Econ Policy Law 2006;1(Pt 2):163-169.
30. Scheuner MT, Wang SJ, Raffel LJ, Larabell SK, Rotter JI. Family history: a comprehensive genetic risk assessment method for the chronic conditions of adulthood. Am J Med Genet 1997;71:315-324.
31. Scheuner MT, McNeel TS, Freedman AN. Population prevalence of familial cancer and common hereditary cancer syndromes. The 2005 California Health Interview Survey. Genet Med 2010;12:726-735.
32. Kawamoto K, Houlihan CA, Balas EA, Lobach DF. Improving clinical practice using clinical decision support systems: a systematic review of trials to identify features critical to success. BMJ 2005;330:765.
33. Qureshi N, Carroll JC, Wilson B, et al. The current state of cancer family history collection tools in primary care: a systematic review. Genet Med 2009;11:495-506.
34. Murff HJ, Byrne D, Haas JS, Puopolo AL, Brennan TA. Race and family history assessment for breast cancer. J Gen Intern Med 2005;20:75-80.
35. Armstrong K, Micco E, Carney A, Stopfer J, Putt M. Racial differences in the use of BRCA1/2 testing among women with a family history of breast or ovarian cancer. JAMA 2005;293:1729-1736.
36. Levy DE, Byfield SD, Comstock CB, et al. Underutilization of BRCA1/2 testing to guide breast cancer treatment: black and Hispanic women particularly at risk. Genet Med 2011;13:349-355.
37. Feero WG. Genetics of common disease: a primary care priority aligned with a teachable moment? Genet Med 2008;10:81-82.
38. Medalie JH, Zyzanski SJ, Langa D, Stange KC. The family in family practice: is it a reality? J Fam Pract 1998;46:390-396.